Increase in pneumococcus macrolide resistance, USA.
Hicks
Lauri A
LA
Monnet
Dominique L
DL
Roberts
Rebecca M
RM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D018942:Macrolides
Lancet. 2005 Feb 12-18;365(9459):579-87
15708101
JAMA. 2001 Oct 17;286(15):1857-62
11597287
J Infect Dis. 2008 Apr 15;197(8):1094-102
18419528
JAMA. 2009 Aug 19;302(7):758-66
19690308
Emerg Infect Dis. 2009 Aug;15(8):1260-4
19751588